<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Critical illness during pregnancy and the peripartum period</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Critical illness during pregnancy and the peripartum period</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Critical illness during pregnancy and the peripartum period</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christine C Reardon, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Felicia Chen, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott Manaker, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David L Hepner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Although fewer than 2 percent of patients require admission to an intensive care unit (ICU) during pregnancy or the peripartum period, defined as the last month of gestation and the first few weeks after delivery, both maternal and fetal mortality are high when such care is required [<a href="#rid1">1-8</a>].</p><p>The disorders that are most common among patients admitted to the ICU during pregnancy or the peripartum period are reviewed here. Issues related to acute respiratory failure during pregnancy and the peripartum period are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1599.html" rel="external">"Acute respiratory failure during pregnancy and the peripartum period"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">INCIDENCE AND MORTALITY</span><span class="headingEndMark"> — </span>The incidence of intensive care unit (ICU) admission for pregnant and postpartum patients ranges from 0.7 to 13.5 per 1000 deliveries [<a href="#rid2">2,9,10</a>]. The most common indications for ICU admission are postpartum hemorrhage and the hypertensive disorders (severe preeclampsia or eclampsia) [<a href="#rid2">2</a>]. However, all medical conditions that can complicate pregnancy can be encountered in the ICU.</p><p>The overall pregnancy-related mortality ratio in the United States is 17.3 deaths per 100,000 live births [<a href="#rid8">8</a>]. In the United States, the leading cause of maternal mortality is death due to cardiovascular disease and cardiomyopathy, which may relate to rising maternal age and high incidence of obesity, diabetes, and hypertension [<a href="#rid8">8,11</a>]. Other common causes of pregnancy-related mortality include venous thromboembolic disease, hemorrhage, infection, and amniotic fluid embolism. According to some studies, more than 60 percent of maternal deaths are preventable [<a href="#rid12">12</a>]. Causes of preventable maternal death included postpartum hemorrhage, preeclampsia, medication errors, and some infections. (See  <a class="medical medical_review" href="/z/d/html/6713.html" rel="external">"Overview of maternal mortality"</a>.)</p><p>In a national database analysis of pregnant females who were critically ill, a 7.8 percent mortality was reported for those who were mechanically ventilated and 5.1 percent for those who had septic shock [<a href="#rid13">13</a>].</p><p>Fetal mortality is also high when critical care is required [<a href="#rid2">2,14-16</a>]. Early gestational age, severe maternal illness, maternal shock, the need for maternal blood transfusions, and the absence of prenatal care are associated with fetal mortality.</p><p class="headingAnchor" id="H21831867"><span class="h1">MANAGEMENT OF SPECIFIC DISEASES</span><span class="headingEndMark"> — </span>Management of critical illness in pregnant and postpartum patients is best done collaboratively with subspecialities including intensivists and obstetric gynecologists [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H67192351"><span class="h2">Cardiovascular disease</span><span class="headingEndMark"> — </span>Maternal cardiac disease and peripartum cardiomyopathy is a major cause of maternal morbidity and mortality that can be encountered in the intensive care unit (ICU). The management of acquired heart disease and peripartum cardiomyopathy are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/8148.html" rel="external">"Acquired heart disease and pregnancy"</a> and  <a class="medical medical_review" href="/z/d/html/4945.html" rel="external">"Peripartum cardiomyopathy: Etiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3507.html" rel="external">"Management of heart failure during pregnancy"</a>.)</p><p class="headingAnchor" id="H67192392"><span class="h2">Venous thromboembolism</span><span class="headingEndMark"> — </span>Venous thromboembolism (VTE) is the fifth leading cause of maternal death in the United States [<a href="#rid1">1,8</a>]. VTE can result in, or complicate, an ICU admission. The diagnosis and management of VTE during pregnancy is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/1349.html" rel="external">"Deep vein thrombosis in pregnancy: Epidemiology, pathogenesis, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/89374.html" rel="external">"Pulmonary embolism in pregnancy: Clinical presentation and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/1350.html" rel="external">"Venous thromboembolism in pregnancy and postpartum: Treatment"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Hemorrhage</span><span class="headingEndMark"> — </span>Severe postpartum hemorrhage is a major cause of maternal ICU admission, accounting for 6.9 to 49 percent of admissions [<a href="#rid1">1,3-8,18,19</a>] and approximately 11 percent of maternal deaths [<a href="#rid1">1,8,19</a>]. The most common causes of postpartum hemorrhage are uterine atony due to poor myometrial contraction after delivery and abnormal placentation, including placenta accreta, placental abruption, and placenta previa.</p><p>The incidence, diagnosis, etiologies, risk factors, management, and complications of postpartum hemorrhage are reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">"Overview of postpartum hemorrhage"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Preeclampsia or eclampsia</span><span class="headingEndMark"> — </span>Preeclampsia and eclampsia are multisystem diseases that develop during pregnancy:</p><p class="bulletIndent1"><span class="glyph">●</span>Preeclampsia is the new onset of hypertension and proteinuria or the new onset of hypertension and end-organ dysfunction with or without proteinuria occurring after 20 weeks of gestation in a previously normotensive patient [<a href="#rid20">20</a>]. Proteinuria is characterized as &gt;0.3 g per day and hypertension is defined as a systolic blood pressure &gt;140 or diastolic blood pressure &gt;90 mmHg. Peripheral edema may be present, but this is not essential for diagnosis. (See  <a class="medical medical_review" href="/z/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eclampsia exists if the features of preeclampsia are accompanied by new-onset seizures. (See  <a class="medical medical_review" href="/z/d/html/1662.html" rel="external">"Eclampsia"</a>.)</p><p></p><p>Complications of the disease are the usual indications for admitting patients with severe preeclampsia or eclampsia to the ICU. Examples include refractory hypertension, neurological dysfunction (eg, seizures, intracranial hemorrhage, elevated intracranial pressure), renal failure, liver rupture, liver failure, pulmonary edema, the HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets), and/or disseminated intravascular coagulation (DIC) [<a href="#rid2">2</a>].</p><p>ICU care involves managing complications including:</p><p class="bulletIndent1"><span class="glyph">●</span>Severe hypertension (ie, systolic BP ≥150 mmHg or diastolic BP ≥100 mmHg and persisting ≥15 minutes) is typically treated with <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a>, <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">hydralazine</a>, or <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">nicardipine</a> [<a href="#rid21">21-25</a>]. Angiotensin-converting enzyme (ACE) inhibitors should be avoided due to their toxic effects on the embryonic kidney. <a class="drug drug_general" data-topicid="9707" href="/z/d/drug information/9707.html" rel="external">Nitroprusside</a> is contraindicated in the later stages of pregnancy due to possible fetal cyanide poisoning if used for more than four hours. The use of antihypertensive agents in pregnancy is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/116432.html" rel="external">"Chronic hypertension in pregnancy: Prenatal and postpartum care"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Seizures should be treated promptly with a bolus of intravenous magnesium, followed by the continuous infusion of <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">magnesium sulfate</a> [<a href="#rid26">26,27</a>]. In addition, supportive care (eg, recovery position, bite protection, supplemental oxygen) is indicated. (See  <a class="medical medical_review" href="/z/d/html/1662.html" rel="external">"Eclampsia", section on 'Prevention of recurrent seizures'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intracerebral hemorrhage requires immediate reversal of any coagulopathy, as well as the discontinuation of any anticoagulant or antiplatelet therapy. Antihypertensive therapy, seizure prophylaxis, and neurosurgical consultation may also be indicated. (See  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Triage'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intracranial hypertension can occur in any patient with severe preeclampsia or eclampsia, but patients who have had an intracerebral hemorrhage are at particularly high risk. Suspected elevated intracranial pressure should prompt elevation of the head of the bed to 30 to 45 degrees, positioning of the head in a midline position to promote venous outflow through the jugular veins, avoidance of hypotonic intravenous fluids, and neurosurgical consultation for potential intracranial pressure monitoring. Sedation and treatment of fever should be optimized. Some patients require osmotic diuresis using hypertonic <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>, <a class="drug drug_general" data-topicid="9587" href="/z/d/drug information/9587.html" rel="external">mannitol</a>, and/or hyperventilation [<a href="#rid28">28,29</a>]. (See  <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults", section on 'ICP monitoring'</a> and  <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults", section on 'General management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary edema may present with dyspnea or acute respiratory failure. Supportive management includes supplemental oxygen and fluid restriction. Diuresis is indicated if there is fluid overload, although this is rare because most patients with severe preeclampsia are volume depleted. (See  <a class="medical medical_review" href="/z/d/html/1599.html" rel="external">"Acute respiratory failure during pregnancy and the peripartum period", section on 'Pulmonary edema'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management of DIC consists of treating the underlying cause, which is frequently placental abruption (abruptio placentae). Aggressive blood component replacement may be necessary when there is severe placental abruption. However, blood products can usually be administered more selectively in the absence of placental abruption. (See  <a class="medical medical_review" href="/z/d/html/1306.html" rel="external">"Evaluation and management of disseminated intravascular coagulation (DIC) in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6803.html" rel="external">"Acute placental abruption: Management and long-term prognosis", section on 'Initial approach for all patients'</a>.)</p><p></p><p>All of these complications are indications for prompt delivery of the fetus, which remains the primary therapy for both preeclampsia and eclampsia.</p><p class="headingAnchor" id="H5"><span class="h2">Acute respiratory failure</span><span class="headingEndMark"> — </span>Acute respiratory failure is a rare complication of pregnancy. It may be due to a conventional respiratory insult or a pregnancy-specific disorder. Examples include pulmonary edema, community-acquired pneumonia, aspiration, pulmonary embolism, asthma exacerbation, amniotic fluid embolism, and venous air embolism [<a href="#rid30">30</a>].</p><p>The clinical presentation, differential diagnosis, diagnosis, and management of acute respiratory failure during pregnancy and the peripartum period are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/1599.html" rel="external">"Acute respiratory failure during pregnancy and the peripartum period"</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Infection/sepsis</span><span class="headingEndMark"> — </span>Obstetrical infections may require ICU admission, particularly if they are complicated by severe sepsis or septic shock, which has been reported to occur in 0.002 to 0.04 percent of all deliveries [<a href="#rid31">31-33</a>]. Such infections are a significant cause of maternal morbidity and mortality [<a href="#rid32">32,34,35</a>]. The reported maternal mortality rate ranges from 12 to 28 percent in pregnant patients with septic shock and multiple organ failure [<a href="#rid33">33,35,36</a>]. Black females, those who smoke cigarettes, and those older than 35 years may be more likely to develop maternal sepsis [<a href="#rid32">32</a>].</p><p>The etiologies of infection during pregnancy are different in the antenatal and postnatal period:</p><p class="bulletIndent1"><span class="glyph">●</span>Antenatal infections – The most common severe infections that occur before delivery are septic abortion, intraamniotic infection (chorioamnionitis), complicated pyelonephritis, and pneumonias caused by Streptococcus pneumoniae and influenza [<a href="#rid35">35-37</a>]. (See  <a class="medical medical_review" href="/z/d/html/6762.html" rel="external">"Clinical chorioamnionitis"</a> and  <a class="medical medical_review" href="/z/d/html/8065.html" rel="external">"Urinary tract infections and asymptomatic bacteriuria in pregnancy", section on 'Acute pyelonephritis'</a> and  <a class="medical medical_review" href="/z/d/html/4793.html" rel="external">"Approach to the pregnant patient with a respiratory infection"</a> and  <a class="medical medical_review" href="/z/d/html/15870.html" rel="external">"Seasonal influenza and pregnancy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postnatal infections – The most common postpartum infection is endometritis. It is usually due to mixed flora, including anaerobic, gram negative, and gram positive organisms. (See  <a class="medical medical_review" href="/z/d/html/5488.html" rel="external">"Postpartum endometritis"</a>.)</p><p></p><p class="bulletIndent1">Other postpartum infections include wound infections, necrotizing fasciitis, toxic shock syndrome, pelvic abscess, gas gangrene of the myometrium (usually due to clostridial species that colonize the GI tract and vagina), septic pelvic thrombophlebitis, pyogenic sacroiliitis [<a href="#rid38">38-41</a>], and <em>Clostridioides difficile</em> colitis [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/5488.html" rel="external">"Postpartum endometritis"</a> and  <a class="medical medical_review" href="/z/d/html/2698.html" rel="external">"<i>Clostridioides difficile</i> infection in adults: Treatment and prevention"</a> and  <a class="medical medical_review" href="/z/d/html/14007.html" rel="external">"Pelvic osteomyelitis and other infections of the bony pelvis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4459.html" rel="external">"Cesarean birth: Postoperative care, complications, and long-term sequelae", section on 'Complications'</a>.)</p><p></p><p>Although there are no prospective studies of early goal-directed therapy during pregnancy, the management of sepsis should be similar to that of the nonpregnant patient and use the same targets [<a href="#rid43">43,44</a>]. However, the SvO<sub>2</sub> decreases in the later stages of the third trimester of pregnancy, so utilizing this target in late pregnancy may be less reliable [<a href="#rid35">35,45,46</a>]. Delivery of the fetus is determined by obstetric indications. Delay in administering antibiotics is associated with an increased mortality, similar to that seen in nonpregnant females with sepsis. One study reported an increase in death from 8.3 percent in females who received antibiotics within one hour of diagnosis to 20 percent in females who received antibiotics later than one hour from the time of diagnosis [<a href="#rid36">36</a>]. The use of vasopressors and management of severe sepsis and septic shock are described separately. (See  <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">"Evaluation and management of suspected sepsis and septic shock in adults"</a> and <a class="local">'Vasopressors'</a> below.)</p><p>The performance characteristics of commonly used sepsis scores are not well studied in pregnant patients but appear to have similar limitations as adults with suspected sepsis who are not pregnant. The systemic inflammatory response system, quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) and modified early warning (MEW) criteria were evaluated in one retrospective study of 82 mothers with sepsis and compared with 328 pregnant patients who did not have sepsis [<a href="#rid36">36</a>]. Among the scores evaluated, SIRS was the most sensitive (0.93) and qSOFA was the most specific (0.95) for the diagnosis of sepsis. However, SIRS was poorly specific (0.63) and qSOFA was poorly sensitive (0.5). The sensitivity and specificity of MEW was 0.82 and 0.87, respectively. The sepsis in obstetrics score (SOS) incorporates clinical criteria that have been modified for expected changes in pregnancy, with a score of &gt;6 predicting the risk of admission to the intensive care unit [<a href="#rid47">47</a>]. This scoring system needs further validation before routine use. (See  <a class="medical medical_review" href="/z/d/html/1657.html" rel="external">"Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis", section on 'Early sepsis'</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Liver disease</span><span class="headingEndMark"> — </span>A variety of diseases may lead to liver failure during pregnancy or the immediate postpartum period [<a href="#rid48">48,49</a>] (see  <a class="medical medical_review" href="/z/d/html/3563.html" rel="external">"Approach to evaluating pregnant patients with elevated liver biochemical and function tests"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Acute fatty liver of pregnancy is a third-trimester disease that occurs in approximately 1 in 13,000 pregnancies [<a href="#rid48">48,49</a>]. Inherited genetic mutations in the intramitochondrial fatty acid oxidation pathway leads to microvesicular fat accumulation within hepatocytes. Patients present with nausea, vomiting, right upper quadrant pain, jaundice, and increased serum aminotransferase (AST) levels (although usually not above 1000 IU/L). Treatment is delivery of the fetus, as well as supportive measures such as mechanical ventilation for coma, dialysis for renal failure, and blood products for coagulopathy. The maternal mortality rate is approximately 7 to 18 percent; however, most survivors have minimal sequelae [<a href="#rid48">48-50</a>]. Fetal mortality is 9 to 23 percent [<a href="#rid49">49,50</a>]. (See  <a class="medical medical_review" href="/z/d/html/3619.html" rel="external">"Acute fatty liver of pregnancy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A variety of liver diseases may occur in individuals with preeclampsia or eclampsia. These include the HELLP syndrome (hemolysis, elevated liver enzymes, low platelets), hepatic hematoma, and hepatic failure. Therapy for the preeclampsia-related liver diseases consists of supportive care and delivery of the fetus. Rupture of a hepatic hematoma is likely to require surgical intervention, preferably by a team experienced in liver trauma surgery. (See  <a class="medical medical_review" href="/z/d/html/6778.html" rel="external">"HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)"</a> and  <a class="medical medical_review" href="/z/d/html/3570.html" rel="external">"Acute liver failure in adults: Management and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Viral hepatitis may occur during pregnancy and lead to fulminant hepatic failure. Findings usually include fever, nausea, right upper quadrant pain, and markedly elevated transaminases (usually above 1000 IU/L). In addition to the hepatitis viruses, herpes simplex virus (HSV) can cause severe hepatitis and should be suspected in the presence of vesicular lesions of the skin. The diagnosis of HSV hepatitis is important because treatment with antiviral agents may be beneficial, though the mortality of this disorder remains very high [<a href="#rid51">51-54</a>]. Treatment for hepatitis caused by other viruses is supportive (see  <a class="medical medical_review" href="/z/d/html/3564.html" rel="external">"Overview of coincident acute hepatobiliary disease in pregnant women"</a> and  <a class="medical medical_review" href="/z/d/html/8334.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of herpes simplex virus type 1 infection"</a>). The treatment of hepatitis C during pregnancy with direct-acting antivirals is not recommended because there are no large trials studying the safety and efficacy of these medications in pregnancy [<a href="#rid53">53</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Thrombotic microangiopathy</span><span class="headingEndMark"> — </span>Thrombotic microangiopathies (TMAs) are a group of systemic diseases characterized by microangiopathic hemolysis, thrombocytopenia, acute renal failure, neurological abnormalities (eg, coma, seizures), and fever. There are three major TMAs: thrombotic thrombocytopenic purpura (TTP), complement-mediated TMA (CM-TMA), and Shiga toxin-mediated hemolytic uremic syndrome (ST-HUS).</p><p class="bulletIndent1"><span class="glyph">●</span>TTP is defined by a severe deficiency of <em>ADAMTS13</em> (defined as activity &lt;10 percent), but the initial diagnosis of TTP generally is based on clinical judgment since <em>ADAMTS13</em> measures are often not available for several days and different methodologies may yield different results. Acquired, autoimmune TTP caused by antibodies to <em>ADAMTS13</em> is more common than hereditary TTP due to <em>ADAMTS13</em> mutation, but individuals with hereditary TTP often have the first presentation of disease during pregnancy. (See  <a class="medical medical_review" href="/z/d/html/88648.html" rel="external">"Diagnostic approach to suspected TTP, HUS, or other thrombotic microangiopathy (TMA)", section on 'Terminology'</a> and  <a class="medical medical_review" href="/z/d/html/1338.html" rel="external">"Diagnosis of immune TTP"</a> and  <a class="medical medical_review" href="/z/d/html/101504.html" rel="external">"Hereditary thrombotic thrombocytopenic purpura (hTTP)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CM-TMA, also known as complement-mediated HUS, is a condition characterized by enhanced activation of complement on endothelial cells, resulting in the formation of microthrombi in small vessels. The kidney is often severely affected. The dysregulation of the complement may be due to a neutralizing autoantibody or an inherited mutation in a complement regulatory gene. (See  <a class="medical medical_review" href="/z/d/html/6084.html" rel="external">"Complement-mediated hemolytic uremic syndrome in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ST-HUS is a disorder in which TMA arises from an intestinal infection with a toxin-producing bacterium. Similar to CM-TMA, the kidneys are frequently impacted. (See  <a class="medical medical_review" href="/z/d/html/6081.html" rel="external">"Clinical manifestations and diagnosis of Shiga toxin-producing Escherichia coli (STEC) hemolytic uremic syndrome in children"</a>.)</p><p></p><p>TTP, CM-TMA, and ST-HUS are rare and potentially lethal diseases. The presentation usually occurs during the second trimester, third trimester, or early postpartum period. The clinical course is unaffected by the delivery of the fetus [<a href="#rid55">55,56</a>]. (See  <a class="medical medical_review" href="/z/d/html/6681.html" rel="external">"Thrombocytopenia in pregnancy", section on 'Thrombotic microangiopathy (TMA)'</a>.)</p><p>TMA can be difficult to differentiate from preeclampsia because the clinical findings overlap and the diseases may occur simultaneously [<a href="#rid56">56</a>]. An onset of illness prior to a gestation age of 20 weeks, the presence of significant hemolysis, and/or a large elevation of lactate dehydrogenase favors TMA. In contrast, significant hypertension, severe liver dysfunction, and/or a large elevation of AST favors preeclampsia [<a href="#rid55">55,56</a>]. Other diseases that should be considered whenever the diagnosis of TMA is entertained include sepsis, malignant hyperthermia, systemic lupus erythematous, and disseminated intravascular coagulation. (See  <a class="medical medical_review" href="/z/d/html/88648.html" rel="external">"Diagnostic approach to suspected TTP, HUS, or other thrombotic microangiopathy (TMA)", section on 'Terminology'</a>.)</p><p>Recognition and diagnosis of TMA is important because aggressive treatment with plasma exchange improves outcome for TTP and anti-complement therapy may rescue renal function in CM-TMA [<a href="#rid55">55,57</a>]. Management of TMA in pregnancy is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6681.html" rel="external">"Thrombocytopenia in pregnancy", section on 'Thrombotic microangiopathy (TMA)'</a> and  <a class="medical medical_review" href="/z/d/html/1344.html" rel="external">"Immune TTP: Initial treatment", section on 'Immune TTP during pregnancy'</a> and  <a class="medical medical_review" href="/z/d/html/101504.html" rel="external">"Hereditary thrombotic thrombocytopenic purpura (hTTP)", section on 'Management of pregnancy'</a> and  <a class="medical medical_review" href="/z/d/html/6084.html" rel="external">"Complement-mediated hemolytic uremic syndrome in children", section on 'Treatment'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Posterior reversible encephalopathy syndrome</span><span class="headingEndMark"> — </span>Posterior reversible encephalopathy syndrome (PRES), also referred to as reversible posterior leukoencephalopathy syndrome, is a radiographic clinical syndrome with reversible subcortical vasogenic edema that can occur during pregnancy, most often in association with eclampsia. It presents with an acute increase in the blood pressure accompanied by headache, seizures, visual deficits, and/or an altered sensorium [<a href="#rid14">14,58-61</a>]. (See  <a class="medical medical_review" href="/z/d/html/4835.html" rel="external">"Reversible posterior leukoencephalopathy syndrome", section on 'Clinical manifestations'</a>.)</p><p>Magnetic resonance imaging (MRI) of the brain is the gold standard for diagnosing PRES. The T2-weighted images typically reveal punctate or confluent symmetric bilateral hyperintensity in the parieto-occipital lobes [<a href="#rid62">62,63</a>]. Computed tomography (CT) demonstrates symmetric hypodensities that usually involve the occipitoparietal regions of the brain [<a href="#rid63">63,64</a>]. (See  <a class="medical medical_review" href="/z/d/html/4835.html" rel="external">"Reversible posterior leukoencephalopathy syndrome", section on 'Neuroimaging'</a>.)</p><p>PRES is associated with severe preeclampsia, renal failure, hypertensive encephalopathy, chemotherapy, and/or immunosuppressive medications [<a href="#rid65">65</a>]. (See  <a class="medical medical_review" href="/z/d/html/4835.html" rel="external">"Reversible posterior leukoencephalopathy syndrome", section on 'Related conditions'</a>.)</p><p>The management of PRES during pregnancy or the peripartum period is similar to the management of PRES when it is associated with another condition. Initial priorities include discontinuing offending medications, lowering the elevated blood pressure, and treating any seizures. (See  <a class="medical medical_review" href="/z/d/html/4835.html" rel="external">"Reversible posterior leukoencephalopathy syndrome", section on 'Management'</a>.)</p><p>There are several aspects of treating PRES that are unique to pregnant patients:</p><p class="bulletIndent1"><span class="glyph">●</span>The fetus should be delivered as soon as possible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a>, <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">hydralazine</a>, and <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">nicardipine</a> are the preferred antihypertensive agents during pregnancy. ACE inhibitors should be avoided due to their toxic effects on the fetal kidney. <a class="drug drug_general" data-topicid="9707" href="/z/d/drug information/9707.html" rel="external">Nitroprusside</a> should be avoided due to its potential to cause fetal cyanide toxicity [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Status epilepticus should be initially treated with <a class="drug drug_general" data-topicid="9585" href="/z/d/drug information/9585.html" rel="external">magnesium sulfate</a> at a dose that is similar to that used to treat preeclampsia or eclampsia (4 to 5 gram bolus intravenously, followed by an infusion of 1 to 2 grams per hour) [<a href="#rid66">66</a>].</p><p></p><p>The neurological and radiographic abnormalities of PRES usually resolve within days to weeks if appropriate treatment is quickly instituted. Neurological deficits may become permanent or fatal if treatment is insufficient or delayed.</p><p class="headingAnchor" id="H10"><span class="h2">Diabetic ketoacidosis</span><span class="headingEndMark"> — </span>Diabetic ketoacidosis (DKA) occurs in approximately 1 to 3 percent of diabetic females who become pregnant, probably because pregnancy predisposes diabetic females to poor glycemic control [<a href="#rid67">67-69</a>]. Maternal mortality related to DKA is &lt;1 percent, however the perinatal mortality of a single episode of DKA is 9 to 35 percent [<a href="#rid67">67,68</a>]. (See  <a class="medical medical_review" href="/z/d/html/4802.html" rel="external">"Pregestational (preexisting) diabetes mellitus: Antenatal glycemic control"</a> and  <a class="medical medical_review" href="/z/d/html/6790.html" rel="external">"Gestational diabetes mellitus: Glucose management and maternal prognosis"</a> and  <a class="medical medical_review" href="/z/d/html/94859.html" rel="external">"Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management"</a> and  <a class="medical medical_review" href="/z/d/html/138420.html" rel="external">"Diabetic ketoacidosis in pregnancy"</a>.)</p><p>The presentation of DKA is similar in pregnant and nonpregnant females, with symptoms of nausea, vomiting, thirst, polyuria, polydipsia, and a change in mental status. Typical laboratory findings include acidemia, an elevated anion gap, renal dysfunction, and hyperglycemia (although as many as 36 percent of pregnant individuals may have blood glucose levels less than 200 mg/dL) [<a href="#rid68">68,70</a>]. Maternal hyperglycemia results in fetal hyperglycemia and fetal osmotic diuresis. Maternal acidemia decreases uterine blood flow with a resultant decrease in placental perfusion leading to decreased oxygen delivery to the fetus. Fetal oxygen delivery is further compromised by the rightward shift of the maternal oxyhemoglobin dissociation curve caused by acidemia. Fetal acidosis and fetal volume depletion may occur, which jeopardizes the viability of the fetus [<a href="#rid68">68,70</a>]. (See  <a class="medical medical_review" href="/z/d/html/1792.html" rel="external">"Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Clinical features, evaluation, and diagnosis"</a>.)</p><p>Other than fetal heart rate monitoring, which is used to assess and monitor the fetus, DKA is treated similarly in pregnant and nonpregnant patients. This includes administration of insulin, replacement of intravascular volume, and repleting electrolytes (including calcium, phosphate, potassium, and magnesium). The cause of the DKA should also be sought. Common etiologies include infection and insulin non-compliance. (See  <a class="medical medical_review" href="/z/d/html/1795.html" rel="external">"Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment"</a> and  <a class="medical medical_review" href="/z/d/html/409.html" rel="external">"Nonstress test and contraction stress test"</a>.)</p><p class="headingAnchor" id="H3145925372"><span class="h2">COVID-19</span><span class="headingEndMark"> — </span>Content that discusses the care of critically ill patients with coronavirus disease 2019 (COVID-19) in nonpregnant and pregnant adults is found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/131224.html" rel="external">"COVID-19: Epidemiology, clinical features, and prognosis of the critically ill adult"</a> and  <a class="medical medical_review" href="/z/d/html/131226.html" rel="external">"COVID-19: Respiratory care of the nonintubated hypoxemic adult (supplemental oxygen, noninvasive ventilation, and intubation)"</a> and  <a class="medical medical_review" href="/z/d/html/127419.html" rel="external">"COVID-19: Management of the intubated adult"</a> and  <a class="medical medical_review" href="/z/d/html/127535.html" rel="external">"COVID-19: Overview of pregnancy issues"</a> and  <a class="medical medical_review" href="/z/d/html/134827.html" rel="external">"COVID-19: Antepartum care of pregnant patients with symptomatic infection"</a>.)</p><p>Limited data are available in pregnant females who were critically ill with COVID-19. One study of 91 pregnant females with critical illness from COVID-19 found similar lung mechanics and ventilatory parameters to those in the nonpregnant population with COVID-19 [<a href="#rid71">71</a>]. Sequential [Sepsis-related] Organ Failure Assessment (SOFA) score was the only risk factor for invasive mechanical ventilation. Fetal delivery was induced mainly for maternal reasons. Risk factors for maternal mortality were body mass index (odds ratio [OR] 1.10, 95% CI 1.00-1.20) and comorbidities (OR 4.15, 95% CI 1.21-14.20). Risk factors for fetal or neonatal mortality were gestational age at delivery and SOFA score. Delivery did not improve ventilatory parameters other than the arterial oxygen tension to fraction of inspired oxygen ratio.</p><p class="headingAnchor" id="H11"><span class="h1">SUPPORTIVE CARE</span><span class="headingEndMark"> — </span>Supportive care refers to interventions that sustain life and prevent complications, but do not treat the underlying cause of the critical illness. This includes oxygenation and ventilation (ie, supplemental oxygen or mechanical ventilation), sedation, pain control, hemodynamic support (ie, vasopressors), monitoring, volume management (ie, intravenous fluids or diuretics), nutritional support, stress ulcer prophylaxis, and venous thromboembolism prophylaxis.</p><p>Mechanical ventilation, sedation, hemodynamic support, and monitoring are discussed in this section. The other interventions that constitute supportive care are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a> and  <a class="medical medical_review" href="/z/d/html/1611.html" rel="external">"Stress ulcers in the intensive care unit: Diagnosis, management, and prevention"</a> and  <a class="medical medical_review" href="/z/d/html/1347.html" rel="external">"Venous thromboembolism in pregnancy: Prevention"</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">Mechanical ventilation</span><span class="headingEndMark"> — </span>Most aspects of mechanical ventilation are identical for pregnant and nonpregnant females. An exception is the target arterial carbon dioxide tension (PaCO<sub>2</sub>):</p><p class="bulletIndent1"><span class="glyph">●</span>Minute ventilation should be adjusted to maintain the PaCO<sub>2</sub> between 30 to 32 mmHg. This replicates normal physiology during pregnancy since pregnant females maintain a respiratory alkalosis (PaCO<sub>2</sub> is approximately 32 mmHg and arterial pH is 7.4 to 7.47) due to respiratory stimulation by progesterone [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/z/d/html/4788.html" rel="external">"Maternal adaptations to pregnancy: Dyspnea and other physiologic respiratory changes", section on 'Physiologic pulmonary changes in pregnancy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A PaCO<sub>2</sub> lower than 30 mmHg should be avoided because significant respiratory alkalosis may decrease uterine blood flow [<a href="#rid72">72</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maternal hypercapnia (PaCO<sub>2</sub> &gt;40 mmHg) causes fetal respiratory acidosis. Thus, it seems prudent to avoid maternal hypercapnia even though studies have not identified any adverse sequelae in fetuses that were exposed to PaCO<sub>2</sub> levels as high as 60 mmHg during permissive hypercapnia [<a href="#rid73">73</a>]. The use of intravenous maternal bicarbonate therapy during permissive hypercapnia is controversial due to conflicting data from animal and human studies [<a href="#rid74">74,75</a>]. (See  <a class="medical medical_review" href="/z/d/html/1645.html" rel="external">"Permissive hypercapnia during mechanical ventilation in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A reasonable goal is a maternal arterial oxygen tension above 70 mmHg, although the optimal oxygen tension and peripheral saturation are unknown.</p><p></p><p>Mechanical ventilation is reviewed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit"</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Sedation</span><span class="headingEndMark"> — </span>Most drugs used for analgesia, sedation, and neuromuscular blockade are capable of getting into the umbilical venous blood and fetal circulation [<a href="#rid76">76-79</a>]. Thus, the potential adverse effects of an agent on the fetus (including teratogenic potential) must be considered when selecting a medication. As a general rule of thumb:</p><p class="bulletIndent1"><span class="glyph">●</span>Analgesia – Any opioid is acceptable. However, nonsteroidal anti-inflammatory drugs should be avoided during late pregnancy because they can cause premature closure of the ductus arteriosus and oligohydramnios.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sedation – Sedation is often required to tolerate mechanical ventilation. There are few reports comparing benzodiazepines with other anxiolytic agents during pregnancy. <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">Midazolam</a> is theoretically superior to <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">lorazepam</a> based upon the observation of teratogenic effects in animal studies of lorazepam; however, the clinical importance of these findings is unclear. <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">Propofol</a> crosses the placenta and may be associated with neonatal respiratory depression. Data on the clinical use of propofol for pregnant critically ill patients is limited to case reports, so its use should be limited until more prospective data is available [<a href="#rid80">80,81</a>]. There are no studies evaluating the safety and effectiveness of <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">dexmedetomidine</a> in the critically ill obstetric patient.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neuromuscular blockade – Use of neuromuscular blocking agents should be avoided unless the patient has refractory respiratory failure despite aggressive sedation. Minimal data are available regarding which neuromuscular blocking agent to use for pregnant patients who require it to facilitate mechanical ventilation. <a class="drug drug_general" data-topicid="9270" href="/z/d/drug information/9270.html" rel="external">Cisatracurium</a> may be preferable as a first-line agent, based upon the observation that it is not affected by renal or hepatic dysfunction [<a href="#rid82">82,83</a>]. By contrast, <a class="drug drug_general" data-topicid="9738" href="/z/d/drug information/9738.html" rel="external">pancuronium</a> can accumulate in the setting of hepatic dysfunction [<a href="#rid84">84</a>]. (See  <a class="medical medical_review" href="/z/d/html/1641.html" rel="external">"Acute respiratory distress syndrome: Fluid management, pharmacotherapy, and supportive care in adults"</a>.)</p><p></p><p>Consultation with an obstetrician and a pharmacist who specializes in the care of pregnant patients may be helpful to facilitate the use of these agents in the intensive care unit (ICU) [<a href="#rid76">76,77,85-88</a>]. A neonatologist should also be present at delivery because analgesics, sedatives, and neuromuscular blocking agents can cause respiratory depression in the newborn. Ventilatory support may be needed for the newborn until the effects of the drugs wear off [<a href="#rid89">89</a>].</p><p>The use of analgesics, sedatives, and neuromuscular blocking agents in critically ill adults is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/1606.html" rel="external">"Sedative-analgesia in ventilated adults: Management strategies, agent selection, monitoring, and withdrawal"</a> and  <a class="medical medical_review" href="/z/d/html/1590.html" rel="external">"Neuromuscular blocking agents in critically ill patients: Use, agent selection, administration, and adverse effects"</a> and  <a class="medical medical_review" href="/z/d/html/2888.html" rel="external">"Pain control in the critically ill adult patient"</a>.)</p><p class="headingAnchor" id="H14"><span class="h2">Vasopressors</span><span class="headingEndMark"> — </span>Vasopressors and inotropes can vasoconstrict uterine blood vessels, reducing fetal blood flow. Thus, other interventions should be used initially to manage hypotension, such as administration of intravenous fluids and placing the patient in the left lateral decubitus position to prevent compression of the inferior vena cava by the gravid uterus. Hypotension that persists despite these initial interventions requires vasopressor therapy, since sustained maternal hypotension decreases uterine blood flow. (See  <a class="medical medical_review" href="/z/d/html/1619.html" rel="external">"Use of vasopressors and inotropes"</a>.)</p><p>There is a paucity of clinical studies with no consensus about which is the best vasopressor for maternal hypotension or shock due to critical illness. In addition, the 2021 sepsis treatment guidelines published by the Society of Critical Care Medicine do not specifically address the care of pregnant patients. However, we agree with others that following these guidelines is reasonable for the management of maternal hypotension from septic shock [<a href="#rid43">43,45,90,91</a>]. Thus, we consider <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> as the first-line vasoactive agent in pregnant patients who fail to respond to early aggressive volume resuscitation. Although norepinephrine can reduce uterine blood flow, there are no data to suggest that norepinephrine has an adverse effect on the well-being of the fetus [<a href="#rid43">43,92</a>]. Thus, we consider this risk to be outweighed by the benefit of maternal resuscitation [<a href="#rid45">45,90</a>].</p><p>For pregnant patients with refractory shock, the best second-line agent is unknown. However, indirect evidence from randomized trials of vasopressors for hypotension caused by spinal anesthesia suggest that <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> may a reasonable second-line agent [<a href="#rid93">93</a>]. Animal models have shown that <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>, phenylephrine, <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a>, and <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> all increase <strong>maternal</strong> blood flow. In contrast, ephedrine is the only agent to increase <strong>uterine</strong> blood flow in animals; all other agents induce vasoconstriction of uterine blood vessels [<a href="#rid92">92-98</a>]. Despite this finding in animals, in human studies ephedrine has been associated with fetal acidosis and phenylephrine is associated with maternal bradycardia [<a href="#rid93">93,98</a>]. Since phenylephrine is not associated with fetal acidosis and maternal bradycardia is easily monitored, we prefer phenylephrine as a second-line agent for septic shock in pregnancy.</p><p>The benefits of <a class="drug drug_general" data-topicid="8535" href="/z/d/drug information/8535.html" rel="external">hydrocortisone</a> in pregnant patients with septic shock are also unstudied. Nonetheless, hydrocortisone can be considered in patients with refractory septic shock who are poorly responsive to both aggressive fluid resuscitation and vasopressor therapy [<a href="#rid91">91</a>]. Unless these conditions are met, we advise against the routine use of corticosteroids in the management of pregnant patients with sepsis or septic shock.</p><p class="headingAnchor" id="H15"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>All pregnant patients should undergo conventional ICU monitoring. This usually includes continuous assessment of the heart rate, cardiac rhythm, oxyhemoglobin saturation, and respiratory rate, as well as frequent evaluation of the blood pressure and temperature.</p><p>Invasive hemodynamic monitoring is occasionally helpful, especially when hypoxemic respiratory failure (eg, pulmonary edema) is accompanied by hypotension and/or renal failure. In these situations, hemodynamic measures can help determine the volume status, which is essential for administration of the optimal balance of intravenous fluids, diuretics, and vasoactive medications [<a href="#rid91">91,99</a>]. (See  <a class="medical medical_review" href="/z/d/html/1593.html" rel="external">"Pulmonary artery catheterization: Indications, contraindications, and complications in adults"</a>.)</p><p>Invasive hemodynamic monitoring is generally accomplished using a central venous catheter to measure the central venous pressure. Pulmonary artery catheters are rarely needed. Interpretation of hemodynamic measures must consider the expected physiologic changes of pregnancy. (See  <a class="medical medical_review" href="/z/d/html/443.html" rel="external">"Maternal adaptations to pregnancy: Cardiovascular and hemodynamic changes"</a> and  <a class="medical medical_review" href="/z/d/html/1595.html" rel="external">"Pulmonary artery catheterization: Interpretation of hemodynamic values and waveforms in adults"</a>.)</p><p>Arterial catheterization may be helpful if the blood pressure is labile or frequent arterial blood gases are needed. (See  <a class="medical medical_review" href="/z/d/html/8174.html" rel="external">"Intra-arterial catheterization for invasive monitoring: Indications, insertion techniques, and interpretation"</a> and  <a class="medical medical_review" href="/z/d/html/1648.html" rel="external">"Arterial blood gases"</a>.)</p><p>Pregnant individuals should have fetal heart rate and uterine monitoring, the frequency of which depends upon the gestational age of the fetus and the clinical scenario.</p><p>Bedside critical care ultrasound is emerging as a useful tool in the assessment of the hypotensive critically ill patient [<a href="#rid100">100</a>]. Transthoracic echocardiography (TTE) may assist in the differentiation of life-threatening hypotension in the critically ill obstetric patient [<a href="#rid101">101</a>]. For example, bedside TTE allows the rapid identification of right ventricular versus left ventricular heart failure thereby allowing the timely administration of appropriate therapy or pursuit of additional testing.</p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Fewer than 2 percent of individuals require admission to an intensive care unit (ICU) during pregnancy or the peripartum period (the last month of gestation and the first few weeks after delivery). Both maternal and fetal mortality are high when critical care is required. (See <a class="local">'Incidence and mortality'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiologies</strong> – The most common indications for ICU admission during pregnancy or the peripartum period are postpartum hemorrhage and the hypertensive disorders (severe preeclampsia or eclampsia). Other indications include cardiovascular disease, venous thromboembolism, acute respiratory failure, infection, hepatic disease (eg, acute fatty liver, the HELLP syndrome [hemolysis, elevated liver enzymes, and low platelets], viral hepatitis), thrombotic microangiopathy (TMA), posterior reversible encephalopathy syndrome, and diabetic ketoacidosis. (See <a class="local">'Cardiovascular disease'</a> above and <a class="local">'Venous thromboembolism'</a> above and <a class="local">'Hemorrhage'</a> above and <a class="local">'Preeclampsia or eclampsia'</a> above and <a class="local">'Acute respiratory failure'</a> above and <a class="local">'Infection/sepsis'</a> above and <a class="local">'Liver disease'</a> above and <a class="local">'Thrombotic microangiopathy'</a> above and <a class="local">'Posterior reversible encephalopathy syndrome'</a> above and <a class="local">'Diabetic ketoacidosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertension</strong> – For pregnant patients who require acute blood pressure control for hypertension (eg, severe preeclampsia or eclampsia), we suggest <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a>, <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">hydralazine</a>, or <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">nicardipine</a> rather than other agents (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). Due to potential harm to the fetus, angiotensin-converting enzyme inhibitors and <a class="drug drug_general" data-topicid="9707" href="/z/d/drug information/9707.html" rel="external">nitroprusside</a> should be avoided during pregnancy. (See <a class="local">'Preeclampsia or eclampsia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supportive care</strong> – Supportive care refers to interventions that sustain life and prevent complications but do not treat the cause of the critical illness. Many of these interventions are not different from those of nonpregnant patients and are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a> and  <a class="medical medical_review" href="/z/d/html/1611.html" rel="external">"Stress ulcers in the intensive care unit: Diagnosis, management, and prevention"</a> and  <a class="medical medical_review" href="/z/d/html/1347.html" rel="external">"Venous thromboembolism in pregnancy: Prevention"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Mechanical ventilation</strong> – Mechanical ventilation is similar for pregnant and nonpregnant females. The major pregnancy-specific considerations are related to the arterial carbon dioxide tension (PaCO<sub>2</sub>). The target PaCO<sub>2</sub> should be between 30 to 32 mmHg, PaCO<sub>2</sub> values &lt;30 mmHg or &gt;40 mmHg should be avoided. A reasonable arterial oxygen tension target goal is 70 mmHg or above. (See <a class="local">'Mechanical ventilation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sedation</strong> – Most drugs used for analgesia, sedation, and paralysis cross the placenta. Thus, the possible adverse effects of the various agents on the fetus (including teratogenic potential) must be considered when selecting an agent. Consultation with an obstetrician and a pharmacist who specializes in the care of pregnant patients may be helpful. A neonatologist should be present at delivery because analgesics, sedatives, and neuromuscular blocking agents can cause respiratory depression in the newborn. (See <a class="local">'Sedation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vasopressors</strong> – Interventions other than vasopressors should be used initially to manage hypotension, including the administration of intravenous fluids and placing the patient in the left lateral decubitus position. Hypotension that persists despite these initial interventions warrants the initiation of a vasopressor, since sustained maternal hypotension decreases uterine blood flow. (See <a class="local">'Vasopressors'</a> above.)</p><p></p><p class="bulletIndent2">For pregnant patients who require vasopressor therapy, we suggest <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> as the initial agent, rather than <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>, <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, or <a class="drug drug_general" data-topicid="9384" href="/z/d/drug information/9384.html" rel="external">dopamine</a> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). For patients with refractory shock despite norepinephrine, we suggest the use of <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> rather than ephedrine (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Vasopressors'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Monitoring</strong> – All patients should undergo conventional ICU monitoring. Invasive hemodynamic monitoring is occasionally helpful, especially when there is hypoxemic respiratory failure (eg, pulmonary edema) accompanied by hypotension and/or renal failure. This is generally accomplished using a central venous catheter to measure the central venous pressure, rather than a pulmonary artery catheter. (See <a class="local">'Monitoring'</a> above.)</p><p></p><p class="headingAnchor" id="H1623107007"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Peter F Clardy, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Zwart JJ, Dupuis JR, Richters A, et al. Obstetric intensive care unit admission: a 2-year nationwide population-based cohort study. Intensive Care Med 2010; 36:256.</a></li><li><a class="nounderline abstract_t">Pollock W, Rose L, Dennis CL. Pregnant and postpartum admissions to the intensive care unit: a systematic review. Intensive Care Med 2010; 36:1465.</a></li><li><a class="nounderline abstract_t">Porreco RP, Barkey R. Peripartum intensive care. J Matern Fetal Neonatal Med 2010; 23:1136.</a></li><li><a class="nounderline abstract_t">Madan I, Puri I, Jain NJ, et al. Characteristics of obstetric intensive care unit admissions in New Jersey. J Matern Fetal Neonatal Med 2009; 22:785.</a></li><li><a class="nounderline abstract_t">Muench MV, Baschat AA, Malinow AM, Mighty HE. Analysis of disease in the obstetric intensive care unit at a university referral center: a 24-month review of prospective data. J Reprod Med 2008; 53:914.</a></li><li><a class="nounderline abstract_t">Wanderer JP, Leffert LR, Mhyre JM, et al. Epidemiology of obstetric-related ICU admissions in Maryland: 1999-2008*. Crit Care Med 2013; 41:1844.</a></li><li><a class="nounderline abstract_t">Orsini J, Butala A, Diaz L, et al. Clinical Profile of Obstetric Patients Admitted to the Medical-Surgical Intensive Care Unit (MSICU) of an Inner-City Hospital in New York. J Clin Med Res 2012; 4:314.</a></li><li class="breakAll">Trends in pregnancy-related mortality in the United States: 1987-2018. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm (Accessed on September 25, 2022).</li><li><a class="nounderline abstract_t">Chantry AA, Deneux-Tharaux C, Bonnet MP, Bouvier-Colle MH. Pregnancy-related ICU admissions in France: trends in rate and severity, 2006-2009. Crit Care Med 2015; 43:78.</a></li><li><a class="nounderline abstract_t">Guntupalli KK, Hall N, Karnad DR, et al. Critical illness in pregnancy: part I: an approach to a pregnant patient in the ICU and common obstetric disorders. Chest 2015; 148:1093.</a></li><li><a class="nounderline abstract_t">Small MJ, James AH, Kershaw T, et al. Near-miss maternal mortality: cardiac dysfunction as the principal cause of obstetric intensive care unit admissions. Obstet Gynecol 2012; 119:250.</a></li><li><a class="nounderline abstract_t">Joseph KS, Boutin A, Lisonkova S, et al. Maternal Mortality in the United States: Recent Trends, Current Status, and Future Considerations. Obstet Gynecol 2021; 137:763.</a></li><li><a class="nounderline abstract_t">Ashana DC, Chen C, Hauschildt K, et al. The Epidemiology of Maternal Critical Illness between 2008 and 2021. Ann Am Thorac Soc 2023; 20:1531.</a></li><li><a class="nounderline abstract_t">Vasquez DN, Estenssoro E, Canales HS, et al. Clinical characteristics and outcomes of obstetric patients requiring ICU admission. Chest 2007; 131:718.</a></li><li><a class="nounderline abstract_t">Cartin-Ceba R, Gajic O, Iyer VN, Vlahakis NE. Fetal outcomes of critically ill pregnant women admitted to the intensive care unit for nonobstetric causes. Crit Care Med 2008; 36:2746.</a></li><li><a class="nounderline abstract_t">Aoyama K, Seaward PG, Lapinsky SE. Fetal outcome in the critically ill pregnant woman. Crit Care 2014; 18:307.</a></li><li><a class="nounderline abstract_t">ACOG Practice Bulletin No. 211: Critical Care in Pregnancy. Obstet Gynecol 2019; 133:e303.</a></li><li><a class="nounderline abstract_t">Leung NY, Lau AC, Chan KK, Yan WW. Clinical characteristics and outcomes of obstetric patients admitted to the Intensive Care Unit: a 10-year retrospective review. Hong Kong Med J 2010; 16:18.</a></li><li><a class="nounderline abstract_t">Einav S, Leone M. Epidemiology of obstetric critical illness. Int J Obstet Anesth 2019; 40:128.</a></li><li><a class="nounderline abstract_t">Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135:e237. Reaffirmed 2023.</a></li><li><a class="nounderline abstract_t">Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1.</a></li><li><a class="nounderline abstract_t">Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2013; :CD001449.</a></li><li><a class="nounderline abstract_t">Firoz T, Magee LA, MacDonell K, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG 2014; 121:1210.</a></li><li><a class="nounderline abstract_t">Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39:3165.</a></li><li><a class="nounderline abstract_t">ACOG Committee Opinion No. 767: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol 2019; 133:e174.</a></li><li><a class="nounderline abstract_t">Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2010; :CD000127.</a></li><li><a class="nounderline abstract_t">Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2010; :CD000128.</a></li><li><a class="nounderline abstract_t">Yundt KD, Diringer MN. The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury. Crit Care Clin 1997; 13:163.</a></li><li><a class="nounderline abstract_t">Frontera JA, Ahmed W. Neurocritical care complications of pregnancy and puerperum. J Crit Care 2014; 29:1069.</a></li><li><a class="nounderline abstract_t">Lapinsky SE. Management of Acute Respiratory Failure in Pregnancy. Semin Respir Crit Care Med 2017; 38:201.</a></li><li><a class="nounderline abstract_t">Bauer ME, Bateman BT, Bauer ST, et al. Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg 2013; 117:944.</a></li><li><a class="nounderline abstract_t">Al-Ostad G, Kezouh A, Spence AR, Abenhaim HA. Incidence and risk factors of sepsis mortality in labor, delivery and after birth: population-based study in the USA. J Obstet Gynaecol Res 2015; 41:1201.</a></li><li><a class="nounderline abstract_t">Hensley MK, Bauer ME, Admon LK, Prescott HC. Incidence of Maternal Sepsis and Sepsis-Related Maternal Deaths in the United States. JAMA 2019; 322:890.</a></li><li><a class="nounderline abstract_t">Paruk F. Infection in obstetric critical care. Best Pract Res Clin Obstet Gynaecol 2008; 22:865.</a></li><li><a class="nounderline abstract_t">Barton JR, Sibai BM. Severe sepsis and septic shock in pregnancy. Obstet Gynecol 2012; 120:689.</a></li><li><a class="nounderline abstract_t">Bauer ME, Housey M, Bauer ST, et al. Risk Factors, Etiologies, and Screening Tools for Sepsis in Pregnant Women: A Multicenter Case-Control Study. Anesth Analg 2019; 129:1613.</a></li><li><a class="nounderline abstract_t">Sheffield JS, Cunningham FG. Community-acquired pneumonia in pregnancy. Obstet Gynecol 2009; 114:915.</a></li><li><a class="nounderline abstract_t">Almoujahed MO, Khatib R, Baran J. Pregnancy-associated pyogenic sacroiliitis: case report and review. Infect Dis Obstet Gynecol 2003; 11:53.</a></li><li><a class="nounderline abstract_t">Liu XQ, Li FC, Wang JW, Wang S. Postpartum septic sacroiliitis misdiagnosed as sciatic neuropathy. Am J Med Sci 2010; 339:292.</a></li><li><a class="nounderline abstract_t">Mulvey JM. Postpartum septic sacroiliitis coincident with labour epidural analgesia. Anaesth Intensive Care 2008; 36:875.</a></li><li><a class="nounderline abstract_t">Knowles SJ, O'Sullivan NP, Meenan AM, et al. Maternal sepsis incidence, aetiology and outcome for mother and fetus: a prospective study. BJOG 2015; 122:663.</a></li><li><a class="nounderline abstract_t">Rouphael NG, O'Donnell JA, Bhatnagar J, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol 2008; 198:635.e1.</a></li><li><a class="nounderline abstract_t">Society for Maternal-Fetal Medicine (SMFM). Electronic address: <span class="__cf_email__" data-cfemail="b1c1c4d3c2f1c2dcd7dc9fdec3d6">[email protected]</span>, Plante LA, Pacheco LD, Louis JM. SMFM Consult Series #47: Sepsis during pregnancy and the puerperium. Am J Obstet Gynecol 2019; 220:B2.</a></li><li><a class="nounderline abstract_t">Bauer ME, Albright C, Prabhu M, et al. Alliance for Innovation on Maternal Health: Consensus Bundle on Sepsis in Obstetric Care. Obstet Gynecol 2023; 142:481.</a></li><li><a class="nounderline abstract_t">Neligan PJ, Laffey JG. Clinical review: Special populations--critical illness and pregnancy. Crit Care 2011; 15:227.</a></li><li><a class="nounderline abstract_t">Clark SL, Cotton DB, Lee W, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 1989; 161:1439.</a></li><li><a class="nounderline abstract_t">Albright CM, Has P, Rouse DJ, Hughes BL. Internal Validation of the Sepsis in Obstetrics Score to Identify Risk of Morbidity From Sepsis in Pregnancy. Obstet Gynecol 2017; 130:747.</a></li><li><a class="nounderline abstract_t">Tran TT, Ahn J, Reau NS. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol 2016; 111:176.</a></li><li><a class="nounderline abstract_t">Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol 2016; 64:933.</a></li><li><a class="nounderline abstract_t">Pereira SP, O'Donohue J, Wendon J, Williams R. Maternal and perinatal outcome in severe pregnancy-related liver disease. Hepatology 1997; 26:1258.</a></li><li><a class="nounderline abstract_t">Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med 2014; 370:2211.</a></li><li><a class="nounderline abstract_t">Masadeh M, Shen H, Lee Y, et al. A fatal case of herpes simplex virus hepatitis in a pregnant patient. Intractable Rare Dis Res 2017; 6:124.</a></li><li class="breakAll">http://www.hcvguidelines.org/ (Accessed on June 15, 2021).</li><li><a class="nounderline abstract_t">Ma K, Berger D, Reau N. Liver Diseases During Pregnancy. Clin Liver Dis 2019; 23:345.</a></li><li><a class="nounderline abstract_t">Fyfe-Brown A, Clarke G, Nerenberg K, et al. Management of pregnancy-associated thrombotic thrombocytopenia purpura. AJP Rep 2013; 3:45.</a></li><li><a class="nounderline abstract_t">Neave L, Scully M. Microangiopathic Hemolytic Anemia in Pregnancy. Transfus Med Rev 2018; 32:230.</a></li><li><a class="nounderline abstract_t">George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 2014; 371:654.</a></li><li><a class="nounderline abstract_t">Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.</a></li><li><a class="nounderline abstract_t">Wagner SJ, Acquah LA, Lindell EP, et al. Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clin Proc 2011; 86:851.</a></li><li><a class="nounderline abstract_t">Staykov D, Schwab S. Posterior reversible encephalopathy syndrome. J Intensive Care Med 2012; 27:11.</a></li><li><a class="nounderline abstract_t">Postma IR, Slager S, Kremer HP, et al. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature. Obstet Gynecol Surv 2014; 69:287.</a></li><li><a class="nounderline abstract_t">Doelken M, Lanz S, Rennert J, et al. Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol 2007; 13:125.</a></li><li><a class="nounderline abstract_t">Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008; 29:1036.</a></li><li><a class="nounderline abstract_t">Finocchi V, Bozzao A, Bonamini M, et al. Magnetic resonance imaging in Posterior Reversible Encephalopathy Syndrome: report of three cases and review of literature. Arch Gynecol Obstet 2005; 271:79.</a></li><li><a class="nounderline abstract_t">Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 2007; 33:230.</a></li><li><a class="nounderline abstract_t">Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of Posterior Reversible Encephalopathy Syndrome (PRES). Med Sci Monit 2005; 11:CR549.</a></li><li><a class="nounderline abstract_t">Carroll MA, Yeomans ER. Diabetic ketoacidosis in pregnancy. Crit Care Med 2005; 33:S347.</a></li><li><a class="nounderline abstract_t">Sibai BM, Viteri OA. Diabetic ketoacidosis in pregnancy. Obstet Gynecol 2014; 123:167.</a></li><li><a class="nounderline abstract_t">Dalfrà MG, Burlina S, Sartore G, Lapolla A. Ketoacidosis in diabetic pregnancy. J Matern Fetal Neonatal Med 2016; 29:2889.</a></li><li><a class="nounderline abstract_t">de Veciana M. Diabetes ketoacidosis in pregnancy. Semin Perinatol 2013; 37:267.</a></li><li><a class="nounderline abstract_t">Vasquez DN, Giannoni R, Salvatierra A, et al. Ventilatory Parameters in Obstetric Patients With COVID-19 and Impact of Delivery: A Multicenter Prospective Cohort Study. Chest 2023; 163:554.</a></li><li><a class="nounderline abstract_t">Motoyama EK, Rivard G, Acheson F, Cook CD. The effect of changes in maternal pH and P-CO2 on the P-O2 of fetal lambs. Anesthesiology 1967; 28:891.</a></li><li><a class="nounderline abstract_t">Ivankovic AD, Elam JO, Huffman J. Effect of maternal hypercarbia on the newborn infant. Am J Obstet Gynecol 1970; 107:939.</a></li><li><a class="nounderline abstract_t">Ralston DH, Shnider SM, DeLorimier AA. Uterine blood flow and fetal acid-base changes after bicarbonate administration to the pregnant ewe. Anesthesiology 1974; 40:348.</a></li><li><a class="nounderline abstract_t">Clark RB, Stephens SR, Greifenstein FE. Fetal and maternal effects of bicarbonate administration during labor. Anesth Analg 1971; 50:713.</a></li><li><a class="nounderline abstract_t">Cravey RH, Reed D. Placental transfer of narcotic analgesics in man. Clin Toxicol 1981; 18:911.</a></li><li><a class="nounderline abstract_t">Johnson RF, Herman N, Arney TL, et al. The placental transfer of sufentanil: effects of fetal pH, protein binding, and sufentanil concentration. Anesth Analg 1997; 84:1262.</a></li><li><a class="nounderline abstract_t">Hawkins JL, Johnson TD, Kubicek MA, et al. Vecuronium for rapid-sequence intubation for cesarean section. Anesth Analg 1990; 71:185.</a></li><li><a class="nounderline abstract_t">Iwama H, Kaneko T, Tobishima S, et al. Time dependency of the ratio of umbilical vein/maternal artery concentrations of vecuronium in caesarean section. Acta Anaesthesiol Scand 1999; 43:9.</a></li><li><a class="nounderline abstract_t">Bacon RC, Razis PA. The effect of propofol sedation in pregnancy on neonatal condition. Anaesthesia 1994; 49:1058.</a></li><li><a class="nounderline abstract_t">Hilton G, Andrzejowski JC. Prolonged propofol infusions in pregnant neurosurgical patients. J Neurosurg Anesthesiol 2007; 19:67.</a></li><li><a class="nounderline abstract_t">De Wolf AM, Freeman JA, Scott VL, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth 1996; 76:624.</a></li><li><a class="nounderline abstract_t">Ward S, Neill EA. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). Br J Anaesth 1983; 55:1169.</a></li><li><a class="nounderline abstract_t">Duvaldestin P, Agoston S, Henzel D, et al. Pancuronium pharmacokinetics in patients with liver cirrhosis. Br J Anaesth 1978; 50:1131.</a></li><li><a class="nounderline abstract_t">Price LC, Slack A, Nelson-Piercy C. Aims of obstetric critical care management. Best Pract Res Clin Obstet Gynaecol 2008; 22:775.</a></li><li><a class="nounderline abstract_t">Ko R, Mazur JE, Pastis NJ, et al. Common problems in critically ill obstetric patients, with an emphasis on pharmacotherapy. Am J Med Sci 2008; 335:65.</a></li><li class="breakAll">Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, Williams and Wilkins, Baltimore 1986.</li><li><a class="nounderline abstract_t">Pacheco LD, Saade GR, Hankins GD. Mechanical ventilation during pregnancy: sedation, analgesia, and paralysis. Clin Obstet Gynecol 2014; 57:844.</a></li><li><a class="nounderline abstract_t">Rochow N, Küster H, Bandt C, et al. Case 1: Unexpected muscular hypotonia and need for mechanical ventilation in a preterm infant. Prolonged effect of diazepam. Acta Paediatr 2008; 97:1602.</a></li><li><a class="nounderline abstract_t">Morgan J, Roberts S. Maternal sepsis. Obstet Gynecol Clin North Am 2013; 40:69.</a></li><li><a class="nounderline abstract_t">Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med 2021; 49:e1063.</a></li><li><a class="nounderline abstract_t">Van Nimwegen D, Dyer DC. The action of vasopressors on isolated uterine arteries. Am J Obstet Gynecol 1974; 118:1099.</a></li><li><a class="nounderline abstract_t">Lee A, Ngan Kee WD, Gin T. A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 2002; 94:920.</a></li><li><a class="nounderline abstract_t">Shnider SM, de Lorimier AA, Holl JW, et al. Vasopressors in obstetrics. I. Correction of fetal acidosis with ephedrine during spinal hypotension. Am J Obstet Gynecol 1968; 102:911.</a></li><li><a class="nounderline abstract_t">GREISS FC, CRANDELL DL. THERAPY FOR HYPOTENSION INDUCED BY SPINAL ANESTHESIA DURING PREGNANCY: OBSERVATIONS ON GRAVID EWES. JAMA 1965; 191:793.</a></li><li><a class="nounderline abstract_t">Clark RB, Brunner JA 3rd. Dopamine for the treatment of spinal hypotension during cesarean section. Anesthesiology 1980; 53:514.</a></li><li><a class="nounderline abstract_t">Moran DH, Perillo M, LaPorta RF, et al. Phenylephrine in the prevention of hypotension following spinal anesthesia for cesarean delivery. J Clin Anesth 1991; 3:301.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Khaw KS, Tan PE, et al. Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology 2009; 111:506.</a></li><li><a class="nounderline abstract_t">Fujitani S, Baldisseri MR. Hemodynamic assessment in a pregnant and peripartum patient. Crit Care Med 2005; 33:S354.</a></li><li><a class="nounderline abstract_t">Blanco P, Abdo-Cuza A. Point-of-care ultrasound in the critically ill pregnant or postpartum patient: what every intensivist should know. Intensive Care Med 2019; 45:1123.</a></li><li><a class="nounderline abstract_t">Dennis AT. Transthoracic echocardiography in obstetric anaesthesia and obstetric critical illness. Int J Obstet Anesth 2011; 20:160.</a></li></ol></div><div id="topicVersionRevision">Topic 1629 Version 46.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19902177" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Obstetric intensive care unit admission: a 2-year nationwide population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20631987" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pregnant and postpartum admissions to the intensive care unit: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20540680" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Peripartum intensive care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19488949" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Characteristics of obstetric intensive care unit admissions in New Jersey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19160649" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Analysis of disease in the obstetric intensive care unit at a university referral center: a 24-month review of prospective data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23648568" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Epidemiology of obstetric-related ICU admissions in Maryland: 1999-2008*.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23024733" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical Profile of Obstetric Patients Admitted to the Medical-Surgical Intensive Care Unit (MSICU) of an Inner-City Hospital in New York.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23024733" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clinical Profile of Obstetric Patients Admitted to the Medical-Surgical Intensive Care Unit (MSICU) of an Inner-City Hospital in New York.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25377016" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pregnancy-related ICU admissions in France: trends in rate and severity, 2006-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26020613" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Critical illness in pregnancy: part I: an approach to a pregnant patient in the ICU and common obstetric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22270275" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Near-miss maternal mortality: cardiac dysfunction as the principal cause of obstetric intensive care unit admissions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33831914" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Maternal Mortality in the United States: Recent Trends, Current Status, and Future Considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37315330" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The Epidemiology of Maternal Critical Illness between 2008 and 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17356085" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clinical characteristics and outcomes of obstetric patients requiring ICU admission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18828192" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Fetal outcomes of critically ill pregnant women admitted to the intensive care unit for nonobstetric causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25042936" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Fetal outcome in the critically ill pregnant woman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31022122" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : ACOG Practice Bulletin No. 211: Critical Care in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20124569" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical characteristics and outcomes of obstetric patients admitted to the Intensive Care Unit: a 10-year retrospective review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31257034" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Epidemiology of obstetric critical illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32443079" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10920346" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23900968" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Drugs for treatment of very high blood pressure during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24832366" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30165544" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30575639" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : ACOG Committee Opinion No. 767: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21154341" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Magnesium sulphate versus diazepam for eclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20927719" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Magnesium sulphate versus phenytoin for eclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9012580" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25123793" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Neurocritical care complications of pregnancy and puerperum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28561251" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Management of Acute Respiratory Failure in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24023020" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25976287" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Incidence and risk factors of sepsis mortality in labor, delivery and after birth: population-based study in the USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31479129" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Incidence of Maternal Sepsis and Sepsis-Related Maternal Deaths in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18693141" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Infection in obstetric critical care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22914482" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Severe sepsis and septic shock in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31743182" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Risk Factors, Etiologies, and Screening Tools for Sepsis in Pregnant Women: A Multicenter Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19888052" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Community-acquired pneumonia in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12839633" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pregnancy-associated pyogenic sacroiliitis: case report and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20090512" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Postpartum septic sacroiliitis misdiagnosed as sciatic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19115661" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Postpartum septic sacroiliitis coincident with labour epidural analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24862293" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Maternal sepsis incidence, aetiology and outcome for mother and fetus: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18395693" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Clostridium difficile-associated diarrhea: an emerging threat to pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30684460" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : SMFM Consult Series #47: Sepsis during pregnancy and the puerperium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37590980" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Alliance for Innovation on Maternal Health: Consensus Bundle on Sepsis in Obstetric Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21888683" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Clinical review: Special populations--critical illness and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2603895" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Central hemodynamic assessment of normal term pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28885400" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Internal Validation of the Sepsis in Obstetrics Score to Identify Risk of Morbidity From Sepsis in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26832651" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : ACG Clinical Guideline: Liver Disease and Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26658682" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Pregnancy and liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9362370" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Maternal and perinatal outcome in severe pregnancy-related liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24897084" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Pregnancy and infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28580213" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A fatal case of herpes simplex virus hepatitis in a pregnant patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28580213" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A fatal case of herpes simplex virus hepatitis in a pregnant patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30947881" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Liver Diseases During Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23943710" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Management of pregnancy-associated thrombotic thrombocytopenia purpura.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30177429" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Microangiopathic Hemolytic Anemia in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25119611" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Syndromes of thrombotic microangiopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8559202" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : A reversible posterior leukoencephalopathy syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21878596" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21257628" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Posterior reversible encephalopathy syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25101694" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17846985" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18356474" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15480723" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Magnetic resonance imaging in Posterior Reversible Encephalopathy Syndrome: report of three cases and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17119920" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Posterior reversible encephalopathy syndrome in intensive care medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16258402" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Clinical spectrum and critical care management of Posterior Reversible Encephalopathy Syndrome (PRES).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16215358" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Diabetic ketoacidosis in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24463678" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Diabetic ketoacidosis in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26461169" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Ketoacidosis in diabetic pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23916025" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Diabetes ketoacidosis in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36257474" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Ventilatory Parameters in Obstetric Patients With COVID-19 and Impact of Delivery: A Multicenter Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6068122" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The effect of changes in maternal pH and P-CO2 on the P-O2 of fetal lambs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5429022" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Effect of maternal hypercarbia on the newborn infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4819090" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Uterine blood flow and fetal acid-base changes after bicarbonate administration to the pregnant ewe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5165422" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Fetal and maternal effects of bicarbonate administration during labor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7318376" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Placental transfer of narcotic analgesics in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9174304" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The placental transfer of sufentanil: effects of fetal pH, protein binding, and sufentanil concentration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1973881" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Vecuronium for rapid-sequence intubation for cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9926180" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Time dependency of the ratio of umbilical vein/maternal artery concentrations of vecuronium in caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7864321" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The effect of propofol sedation in pregnancy on neonatal condition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17198107" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Prolonged propofol infusions in pregnant neurosurgical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8688259" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6689126" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/718783" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Pancuronium pharmacokinetics in patients with liver cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18693071" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Aims of obstetric critical care management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18195587" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Common problems in critically ill obstetric patients, with an emphasis on pharmacotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18195587" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Common problems in critically ill obstetric patients, with an emphasis on pharmacotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25264701" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Mechanical ventilation during pregnancy: sedation, analgesia, and paralysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19032348" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Case 1: Unexpected muscular hypotonia and need for mechanical ventilation in a preterm infant. Prolonged effect of diazepam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23466138" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Maternal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34605781" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4817644" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The action of vasopressors on isolated uterine arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11916798" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5724395" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Vasopressors in obstetrics. I. Correction of fetal acidosis with ephedrine during spinal hypotension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14250063" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : THERAPY FOR HYPOTENSION INDUCED BY SPINAL ANESTHESIA DURING PREGNANCY: OBSERVATIONS ON GRAVID EWES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7457972" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Dopamine for the treatment of spinal hypotension during cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1910798" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Phenylephrine in the prevention of hypotension following spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19672175" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16215359" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Hemodynamic assessment in a pregnant and peripartum patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31270577" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Point-of-care ultrasound in the critically ill pregnant or postpartum patient: what every intensivist should know.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21315578" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Transthoracic echocardiography in obstetric anaesthesia and obstetric critical illness.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
